Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doina Ivan

Showing results (111-120 of 140) with videos related to

Pageof 14
Sort By:
Journal of Cutaneous Pathology|August 18, 2016
Loss of CD30 expression after treatment with brentuximab vedotin in a patient with anaplastic large cell lymphoma: a novel findingRami N Al-Rohil, Carlos A Torres-Cabala, Anisha Patel, et al.
The American Journal of Dermatopathology|April 21, 2020
BAP-1 Expression Status by Immunohistochemistry in Cellular Blue Nevus and Blue Nevus-like MelanomaPei-Ling Chen, Nastaran Neishaboori, Michael T Tetzlaff, et al.
Frontiers in Oncology|March 22, 2021
Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity ReactionPaul V Viscuse, Mario L Marques-Piubelli, Meghan M Heberton, et al.
Journal of Cutaneous Pathology|January 6, 2025
Genomic and Transcriptomic Profiling of Digital Papillary Adenocarcinomas Reveals Alterations in Matrix Remodeling and Metabolic GenesErol Can Bayraktar, Phyu P Aung, Pavandeep Gill, et al.
Journal of Cutaneous Pathology|April 11, 2018
Dermatologic toxicity from immune checkpoint blockade therapy with an interstitial granulomatous patternCelestine Trinidad, Kelly C Nelson, Isabella C Glitza Oliva, et al.
Archives of Pathology & Laboratory Medicine|December 8, 2020
Prognostic Significance of Subungual Anatomic Site in Acral Lentiginous MelanomaHaider A Mejbel, Carlos A Torres-Cabala, Denái R Milton, et al.
Journal of Cutaneous Pathology|July 10, 2020
Langerhans cell sarcoma involving skin and showing epidermotropism: A comprehensive reviewShira Ronen, Elizabeth Keiser, Katrina M Collins, et al.
The American Journal of Dermatopathology|April 23, 2009
Cutaneous hidradenocarcinoma: a clinicopathological, immunohistochemical, and molecular biologic study of 14 cases, including Her2/neu gene expression/amplification, TP53 gene mutation analysis, and t(11;19) translocationDmitry V Kazakov, Doina Ivan, Heinz Kutzner, et al.
Virchows Archiv : an International Journal of Pathology|February 19, 2021
Is immunohistochemical expression of GATA3 helpful in the differential diagnosis of transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders?Katrina Collins, Jun Gu, Phyu P Aung, et al.
Journal of Cutaneous Pathology|June 5, 2026
Dermatologic Toxicities Associated With Novel Pan-RAS/RAF InhibitorsLin J He, Shaymaa Hegazy, Phyu P Aung, et al.
Pageof 14

Showing results (111-120 of 140) with videos related to

Sort By:
Pageof 14
Journal of Cutaneous Pathology|August 18, 2016
Loss of CD30 expression after treatment with brentuximab vedotin in a patient with anaplastic large cell lymphoma: a novel findingRami N Al-Rohil, Carlos A Torres-Cabala, Anisha Patel, et al.
The American Journal of Dermatopathology|April 21, 2020
BAP-1 Expression Status by Immunohistochemistry in Cellular Blue Nevus and Blue Nevus-like MelanomaPei-Ling Chen, Nastaran Neishaboori, Michael T Tetzlaff, et al.
Frontiers in Oncology|March 22, 2021
Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity ReactionPaul V Viscuse, Mario L Marques-Piubelli, Meghan M Heberton, et al.
Journal of Cutaneous Pathology|January 6, 2025
Genomic and Transcriptomic Profiling of Digital Papillary Adenocarcinomas Reveals Alterations in Matrix Remodeling and Metabolic GenesErol Can Bayraktar, Phyu P Aung, Pavandeep Gill, et al.
Journal of Cutaneous Pathology|April 11, 2018
Dermatologic toxicity from immune checkpoint blockade therapy with an interstitial granulomatous patternCelestine Trinidad, Kelly C Nelson, Isabella C Glitza Oliva, et al.
Archives of Pathology & Laboratory Medicine|December 8, 2020
Prognostic Significance of Subungual Anatomic Site in Acral Lentiginous MelanomaHaider A Mejbel, Carlos A Torres-Cabala, Denái R Milton, et al.
Journal of Cutaneous Pathology|July 10, 2020
Langerhans cell sarcoma involving skin and showing epidermotropism: A comprehensive reviewShira Ronen, Elizabeth Keiser, Katrina M Collins, et al.
The American Journal of Dermatopathology|April 23, 2009
Cutaneous hidradenocarcinoma: a clinicopathological, immunohistochemical, and molecular biologic study of 14 cases, including Her2/neu gene expression/amplification, TP53 gene mutation analysis, and t(11;19) translocationDmitry V Kazakov, Doina Ivan, Heinz Kutzner, et al.
Virchows Archiv : an International Journal of Pathology|February 19, 2021
Is immunohistochemical expression of GATA3 helpful in the differential diagnosis of transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders?Katrina Collins, Jun Gu, Phyu P Aung, et al.
Journal of Cutaneous Pathology|June 5, 2026
Dermatologic Toxicities Associated With Novel Pan-RAS/RAF InhibitorsLin J He, Shaymaa Hegazy, Phyu P Aung, et al.
Pageof 14